Clinical outcomes for young children diagnosed with asthma versus reactive airway disease

2021 ◽  
Author(s):  
Sean M. Frey ◽  
Nicolas P.N. Goldstein ◽  
Veronica Kwiatkowski ◽  
Ariel Reinish
Keyword(s):  
Young Children ◽  
Clinical Outcomes ◽  
Airway Disease ◽  
Reactive Airway Disease ◽  
Reactive Airway

Delivering Nebulized Medication to Infants and Toddlers

1996 ◽  
Vol 17 (9) ◽  
pp. 327-327
Author(s):  
James Seidel
Keyword(s):  
Young Children ◽  
Airway Disease ◽  
Dose Inhaler ◽  
Systemic Effects ◽  
Infants And Toddlers ◽  
Metered Dose Inhaler ◽  
Reactive Airway Disease ◽  
Reactive Airway ◽  
Metered Dose ◽  
Infants And Young Children

Several aerosolized drugs are available for the management of reactive airway disease. Nebulized drugs are given directly into the airway, which minimizes the systemic effects of musculoskeletal tremor, anxiety, and cardiovascular stimulation in most patients. Although infants and young children can be given medication via a metered dose inhaler that has a spacer, these children may not generate enough inspiratory pressure to open the oneway valve on the spacer fully.

Montelukast does not prevent reactive airway disease in young children hospitalized for RSV bronchiolitis

2009 ◽  
Vol 98 (11) ◽  
pp. 1830-1834 ◽  
Author(s):  
M Proesmans ◽  
K Sauer ◽  
E Govaere ◽  
M Raes ◽  
G De Bilderling ◽  
...  
Keyword(s):  
Young Children ◽  
Airway Disease ◽  
Reactive Airway Disease ◽  
Reactive Airway

THE EFFECT OF AGE ON BRONCHODILATOR RESPONSIVENESS

PEDIATRICS ◽  
1994 ◽  
Vol 94 (2) ◽  
pp. 263-263
Author(s):  
Bradley E. Chipps
Keyword(s):  
Young Children ◽  
Dose Response ◽  
Response Curve ◽  
Airway Disease ◽  
Beta Agonist ◽  
Older Children ◽  
Reactive Airway Disease ◽  
Reactive Airway ◽  
Bronchodilator Responsiveness ◽  
Effect Of Age

Young children (<3 yrs) can be trained to do forced expiratory maneuvers and appear not to respond as well to inhaled beta agonist. The finding may be underestimated in the study, because the patients received the same dose of beta agonist. Even though older children received less beta agonist per kilogram, they responded to a greater degree and did not reach a plateau in the dose response curve after the last nebulized dose. These findings should be considered in the dosing recommendations for beta agonist for the treatment of reactive airway disease.

Reactive Airway Disease and the Management of Samter’s Triad

2008 ◽  
pp. 1-17
Author(s):  
Roxanne S. Leung ◽  
Rohit K. Katial ◽  
Todd T. Kingdom
Keyword(s):  
Airway Disease ◽  
Reactive Airway Disease ◽  
Reactive Airway ◽  
Samter’S Triad

Primary Tracheal Papillomatosis Presenting as Reactive Airway Disease

2002 ◽  
Vol 126 (1) ◽  
pp. 79-80 ◽  
Author(s):  
Joseph Valentino ◽  
C. Blake Brame ◽  
Karl E. Studtmann ◽  
Jose M. Manaligod
Keyword(s):  
Airway Disease ◽  
Reactive Airway Disease ◽  
Reactive Airway
Sign in / Sign up

Export Citation Format

Share Document